Complete Filing Data
Cogent Biosciences, Inc. reported Net Income Loss of -$328.94 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Cogent Biosciences, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$328.9M | -$255.9M | -$192.4M | -$140.2M | -$72.3M | -$74.8M | -$31.8M | -$34.5M | -$25.5M |
| Revenue * | $7.9M | $22.5M | $9.7M | $8.4M | |||||
| Operating Income Loss | -$333.4M | -$275.9M | -$208.1M | -$147.8M | -$75.6M | -$82.2M | -$32.2M | -$36.0M | -$26.2M |
| Research And Development Expense | $269.8M | $232.7M | $173.8M | $121.6M | $55.9M | $25.7M | $43.7M | $38.3M | $29.8M |
| Nonoperating Income Expense | $4.4M | $20.1M | $15.7M | $7.6M | $3.3M | $7.4M | $345.0K | $1.5M | $660.0K |
| General And Administrative Expense | $63.6M | $43.3M | $34.4M | $26.2M | $19.6M | $17.4M | $11.0M | $7.5M | $4.7M |
| Comprehensive Income Net Of Tax | -$329.0M | -$255.7M | -$192.1M | -$140.3M | -$72.3M | -$74.8M | -$31.8M | -$34.5M | -$25.5M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$92.0K | $201.0K | $350.0K | -$104.0K | $0.00 | $12.0K | $4.0K | $8.0K | |
| Other Comprehensive Income Loss Net Of Tax | -$92.0K | $201.0K | $350.0K | -$104.0K | $0.00 | $12.0K | $4.0K | $8.0K | |
| Other Nonoperating Income Expense | -$20.0K | $2.0M | $943.0K | $78.0K | $320.0K | $274.0K | |||
| Net Income Loss Available To Common Stockholders Basic | -$72.3M | -$179.2M | -$31.8M | -$34.5M | -$25.6M | ||||
| Other Nonoperating Income | $2.0M | $943.0K | $2.2M | $2.5M | $779.0K | ||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | -$92.0K | $201.0K | $350.0K | -$104.0K | |||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$80.9M | -$73.5M | -$72.0M | -$70.6M | -$59.0M | -$58.3M | -$55.4M | -$44.1M | -$38.6M | -$35.1M | -$34.9M | -$30.6M | -$19.1M | -$16.5M | -$11.7M | -$50.0M | -$7.4M | -$6.1M | $2.3M | -$11.9M | -$10.5M | -$11.7M | -$8.6M | -$10.2M | -$9.0M | -$6.7M | -$6.7M | -$7.0M | -$5.9M | -$5.9M |
| Revenue * | $312.0K | $528.0K | $7.0M | $15.3M | $1.0M | $3.1M | $3.1M | $3.8M | $2.0M | $1.7M | $2.2M | $2.1M | $2.3M | $2.1M | $1.8M | |||||||||||||||
| Operating Income Loss | -$83.4M | -$75.6M | -$74.9M | -$75.4M | -$64.4M | -$62.4M | -$59.6M | -$47.1M | -$43.2M | -$36.8M | -$35.9M | -$31.4M | -$19.8M | -$17.3M | -$12.8M | -$57.2M | -$7.4M | -$6.1M | $2.2M | -$12.0M | -$10.5M | -$11.8M | -$9.0M | -$10.6M | -$9.4M | -$7.0M | -$6.9M | -$7.2M | -$6.0M | -$6.1M |
| Research And Development Expense | $69.0M | $62.2M | $63.0M | $63.6M | $54.3M | $52.7M | $50.1M | $38.9M | $36.0M | $29.9M | $29.5M | $25.5M | $14.8M | $12.4M | $8.2M | $5.0M | $5.1M | $9.5M | $10.3M | $10.6M | $12.4M | $10.3M | $9.1M | $8.1M | $8.2M | $7.1M | $7.0M | |||
| Nonoperating Income Expense | $2.4M | $2.1M | $2.9M | $4.8M | $5.4M | $4.1M | $4.2M | $3.0M | $4.7M | $1.8M | $928.0K | $784.0K | $735.0K | $743.0K | $1.1M | $7.2M | $10.0K | $47.0K | $113.0K | $25.0K | $150.0K | $408.0K | $416.0K | $251.0K | $170.0K | $170.0K | $130.0K | |||
| General And Administrative Expense | $14.4M | $13.4M | $11.9M | $11.8M | $10.1M | $9.7M | $9.5M | $8.2M | $7.2M | $6.9M | $6.4M | $5.9M | $5.0M | $4.9M | $4.6M | $5.6M | $2.8M | $3.7M | $2.7M | $3.1M | $2.5M | $2.4M | $2.0M | $1.1M | $1.3M | $971.0K | $944.0K | |||
| Comprehensive Income Net Of Tax | -$80.7M | -$73.7M | -$72.3M | -$69.5M | -$59.1M | -$58.6M | -$55.5M | -$44.2M | -$38.5M | -$35.2M | -$34.9M | -$30.6M | -$19.1M | -$16.5M | -$11.7M | -$50.0M | -$7.4M | -$6.1M | -$11.9M | -$10.5M | -$11.7M | -$10.2M | -$9.0M | -$6.7M | -$7.0M | -$5.9M | -$6.0M | |||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $195.0K | -$151.0K | -$283.0K | $1.1M | -$153.0K | -$285.0K | -$75.0K | -$113.0K | $120.0K | -$163.0K | $2.0K | $10.0K | -$11.0K | -$6.0K | $9.0K | $19.0K | -$7.0K | -$12.0K | ||||||||||||
| Other Comprehensive Income Loss Net Of Tax | $195.0K | -$151.0K | -$283.0K | $1.1M | -$153.0K | -$285.0K | -$75.0K | -$113.0K | $120.0K | -$163.0K | $2.0K | $10.0K | -$11.0K | -$6.0K | $9.0K | $19.0K | -$7.0K | -$12.0K | ||||||||||||
| Other Nonoperating Income Expense | -$3.0K | -$6.0K | -$5.0K | $1.0K | $44.0K | -$1.0K | $0.00 | $268.0K | $682.0K | $7.0K | $82.0K | $3.0K | $157.0K | $170.0K | $70.0K | $73.0K | ||||||||||||||
| Net Income Loss Available To Common Stockholders Basic | $2.3M | -$11.9M | -$10.5M | -$11.7M | -$8.6M | -$10.2M | -$9.0M | -$6.8M | -$6.7M | -$7.0M | -$5.9M | -$6.0M | ||||||||||||||||||
| Other Nonoperating Income | $268.0K | $682.0K | $259.0K | $656.0K | $677.0K | $620.0K | $623.0K | $604.0K | $239.0K | $7.0K | $170.0K | $40.0K | ||||||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | $195.0K | -$151.0K | -$283.0K | $1.1M | -$153.0K | -$285.0K | -$75.0K | -$113.0K | $120.0K | -$163.0K | ||||||||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $636.4M | $256.3M | $257.8M | $255.7M | $214.2M | $234.7M | $31.8M | $60.2M | -$48.8M | -$24.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $312.4M | $98.2M | $53.2M | $141.1M | $220.9M | $243.4M | $38.7M | $56.9M | $29.6M | $42.6M |
| Retained Earnings Accumulated Deficit | -$1.19B | -$859.5M | -$603.6M | -$411.2M | -$271.0M | -$198.7M | -$123.9M | -$92.1M | -$51.3M | |
| Property Plant And Equipment Net | $5.5M | $6.5M | $8.3M | $7.8M | $1.7M | $134.0K | $1.9M | $3.3M | $4.1M | |
| Prepaid Expense And Other Assets Current | $9.6M | $9.4M | $5.1M | $4.4M | $2.9M | $2.7M | $1.2M | $740.0K | $513.0K | |
| Liabilities Current | $64.0M | $55.7M | $38.2M | $26.8M | $17.1M | $13.1M | $13.2M | $24.9M | $11.2M | |
| Liabilities And Stockholders Equity | $937.6M | $327.9M | $313.4M | $300.8M | $232.1M | $250.9M | $49.4M | $85.9M | $49.1M | |
| Liabilities | $301.2M | $71.6M | $55.6M | $45.1M | $17.9M | $16.2M | $17.7M | $25.7M | $20.8M | |
| Common Stock Value | $161.0K | $110.0K | $86.0K | $70.0K | $44.0K | $32.0K | $8.0K | $30.0K | $10.0K | |
| Cash And Cash Equivalents At Carrying Value | $312.0M | $98.2M | $53.2M | $139.9M | $219.7M | $242.2M | $37.4M | $55.7M | $28.3M | |
| Assets Current | $910.4M | $296.5M | $270.8M | $265.0M | $222.6M | $244.9M | $40.6M | $81.0M | $42.4M | |
| Assets | $937.6M | $327.9M | $313.4M | $300.8M | $232.1M | $250.9M | $49.4M | $85.9M | $49.1M | |
| Additional Paid In Capital Common Stock | $1.73B | $1.00B | $801.1M | $601.2M | $399.7M | $322.5M | $155.6M | $152.3M | $2.5M | |
| Accounts Payable Current | $9.5M | $12.0M | $10.7M | $5.8M | $3.5M | $732.0K | $3.2M | $1.5M | $1.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $214.3M | $44.9M | -$87.9M | -$79.8M | -$22.5M | $204.8M | -$18.2M | $27.3M | -$13.0M | |
| Operating Lease Right Of Use Asset | $18.1M | $20.1M | $22.0M | $23.3M | $2.8M | $4.6M | $5.3M | |||
| Accrued Expenses And Other Liabilities Current | $52.9M | $42.1M | $26.1M | $17.9M | $8.2M | $4.8M | $7.1M | $5.5M | $3.0M | |
| Operating Lease Liability Noncurrent | $14.4M | $15.9M | $17.5M | $18.2M | $831.0K | $3.2M | $4.4M | |||
| Operating Lease Liability Current | $1.5M | $1.6M | $1.4M | $1.4M | $2.3M | $2.1M | $1.6M | |||
| Other Assets Noncurrent | $3.3M | $4.9M | $4.9M | $4.7M | $3.7M | $427.0K | $419.0K | |||
| Accretion Amortization Of Discounts And Premiums Investments | $2.0M | $7.6M | $5.2M | $1.6M | $0.00 | $53.0K | $246.0K | -$17.0K | ||
| Restricted Cash Noncurrent | $416.0K | $0.00 | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $355.0K | $447.0K | $246.0K | -$104.0K | -$12.0K | -$16.0K | ||||
| Change In Fair Value Of Contingent Value Right Liability | $0.00 | $0.00 | -$1.7M | -$1.4M | -$343.0K | $1.0M | ||||
| Operating Lease Right Of Use Asset Amortization Expense | $2.0M | $1.9M | $1.3M | $5.0M | $1.8M | |||||
| Convertible Preferred Stock Converted To Other Securities | $5.8M | $19.6M | $25.5M | $27.4M | $77.2M | |||||
| Offering Costs Included In Accounts Payable And Accrued Expenses | $64.0K | $49.0K | $30.0K | $30.0K | $0.00 | |||||
| Available For Sale Securities Debt Securities Current | $588.8M | $188.9M | $212.5M | $119.4M | $0.00 | |||||
| Property And Equipment Included In Accounts Payable And Accrued Expenses | $0.00 | $0.00 | $43.0K | $58.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $302.5M | $155.0M | $219.0M | $314.7M | $373.2M | $422.3M | $302.9M | $348.4M | $223.6M | $289.9M | $319.4M | $187.9M | $197.2M | $212.8M | $226.8M | -$22.2M | $19.2M | $25.7M | $28.6M | $39.8M | $49.3M | $67.5M | $76.7M | -$61.3M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $125.6M | $127.6M | $126.0M | $97.0M | $88.2M | $215.8M | $86.8M | $214.3M | $162.0M | $141.8M | $326.8M | $192.3M | $204.1M | $219.4M | $232.0M | $130.7M | $22.6M | $30.9M | $47.1M | $57.1M | $60.4M | $50.6M | $48.0M | $27.0M | $32.0M | $32.5M | $34.5M |
| Retained Earnings Accumulated Deficit | -$1.09B | -$1.00B | -$931.5M | -$791.6M | -$720.9M | -$662.0M | -$549.3M | -$493.9M | -$449.8M | -$371.6M | -$336.5M | -$301.6M | -$246.1M | -$227.0M | -$210.4M | -$187.4M | -$137.4M | -$130.0M | -$126.2M | -$114.3M | -$103.8M | -$83.5M | -$73.3M | -$64.3M | |||
| Property Plant And Equipment Net | $5.3M | $5.9M | $6.5M | $7.0M | $7.4M | $7.8M | $8.6M | $9.1M | $9.0M | $6.5M | $3.6M | $2.1M | $1.3M | $226.0K | $117.0K | $153.0K | $1.3M | $1.6M | $2.2M | $2.6M | $3.0M | $3.6M | $3.9M | $3.9M | |||
| Prepaid Expense And Other Assets Current | $6.4M | $7.2M | $7.2M | $6.0M | $6.8M | $6.2M | $6.9M | $5.1M | $4.8M | $6.1M | $3.9M | $3.7M | $4.6M | $3.2M | $1.3M | $4.0M | $2.6M | $1.6M | $1.2M | $1.2M | $757.0K | $960.0K | $1.4M | $1.2M | |||
| Liabilities Current | $62.2M | $58.4M | $49.3M | $53.0M | $40.0M | $36.7M | $34.7M | $25.8M | $21.1M | $23.6M | $27.7M | $17.9M | $16.7M | $13.7M | $8.2M | $20.1M | $8.3M | $9.3M | $24.4M | $24.3M | $26.3M | $26.4M | $24.8M | $23.0M | |||
| Liabilities And Stockholders Equity | $425.9M | $274.8M | $283.8M | $384.0M | $429.9M | $476.1M | $355.4M | $392.4M | $263.2M | $331.6M | $366.1M | $206.9M | $215.4M | $228.5M | $237.6M | $139.9M | $31.1M | $38.9M | $57.9M | $69.3M | $81.3M | $94.8M | $102.7M | $43.4M | |||
| Liabilities | $123.5M | $119.8M | $64.8M | $69.4M | $56.7M | $53.8M | $52.5M | $43.9M | $39.6M | $41.6M | $46.7M | $19.0M | $18.1M | $15.7M | $10.8M | $23.8M | $11.8M | $13.2M | $29.3M | $29.6M | $32.0M | $27.3M | $26.0M | $27.5M | |||
| Common Stock Value | $141.0K | $114.0K | $114.0K | $110.0K | $109.0K | $96.0K | $86.0K | $85.0K | $71.0K | $70.0K | $66.0K | $46.0K | $40.0K | $40.0K | $37.0K | $11.0K | $32.0K | $31.0K | $30.0K | $30.0K | $30.0K | $30.0K | $30.0K | $10.0K | |||
| Cash And Cash Equivalents At Carrying Value | $125.3M | $127.6M | $126.0M | $97.0M | $88.2M | $215.8M | $86.8M | $214.3M | $160.7M | $140.6M | $325.6M | $191.0M | $202.9M | $218.1M | $230.7M | $129.4M | $21.3M | $29.6M | $45.9M | $55.9M | $59.1M | $49.3M | $46.7M | $25.7M | |||
| Assets Current | $397.2M | $245.0M | $252.9M | $341.5M | $370.0M | $441.9M | $286.0M | $334.5M | $226.3M | $296.4M | $330.7M | $194.7M | $207.5M | $221.4M | $232.1M | $133.4M | $23.9M | $31.2M | $48.0M | $58.6M | $69.9M | $89.5M | $97.1M | $35.2M | |||
| Assets | $425.9M | $274.8M | $283.8M | $384.0M | $429.9M | $476.1M | $355.4M | $392.4M | $263.2M | $331.6M | $366.1M | $206.9M | $215.4M | $228.5M | $237.6M | $139.9M | $31.1M | $38.9M | $57.9M | $69.3M | $81.3M | $94.8M | $102.7M | $43.4M | |||
| Additional Paid In Capital Common Stock | $1.28B | $1.05B | $1.04B | $994.6M | $980.1M | $862.1M | $792.2M | $780.0M | $611.0M | $595.8M | $584.5M | $411.0M | $357.9M | $354.3M | $342.5M | $165.2M | $156.6M | $155.7M | $154.8M | $154.0M | $153.0M | $151.0M | $149.9M | $3.0M | |||
| Accounts Payable Current | $16.0M | $16.6M | $14.2M | $15.1M | $9.0M | $15.6M | $9.9M | $7.2M | $4.2M | $4.1M | $3.5M | $4.0M | $4.3M | $2.0M | $315.0K | $639.0K | $632.0K | $628.0K | $1.6M | $1.7M | $1.8M | $803.0K | $1.7M | $3.1M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $27.8M | $162.6M | $20.8M | -$28.6M | -$11.5M | -$7.8M | $3.4M | -$2.6M | |||||||||||||||||||
| Operating Lease Right Of Use Asset | $18.6M | $19.1M | $19.6M | $20.6M | $21.1M | $21.5M | $22.2M | $22.5M | $23.1M | $23.8M | $26.9M | $3.2M | $3.2M | $3.7M | $4.2M | $5.0M | $4.6M | $4.9M | $5.6M | $6.0M | $6.3M | ||||||
| Accrued Expenses And Other Liabilities Current | $44.5M | $40.1M | $33.6M | $36.5M | $29.6M | $19.7M | $23.5M | $17.4M | $16.0M | $14.4M | $12.0M | $8.4M | $7.0M | $6.4M | $8.2M | $5.5M | $5.6M | $6.1M | $6.5M | $5.9M | $6.1M | ||||||
| Operating Lease Liability Noncurrent | $14.6M | $15.1M | $15.5M | $16.3M | $16.7M | $17.1M | $17.8M | $18.2M | $18.5M | $18.1M | $19.0M | $1.1M | $1.4M | $2.0M | $2.6M | $3.7M | $3.5M | $4.0M | $4.8M | $5.2M | $5.6M | ||||||
| Operating Lease Liability Current | $1.7M | $1.7M | $1.6M | $1.5M | $1.5M | $1.4M | $1.3M | $1.2M | $947.0K | $2.0M | $9.1M | $2.4M | $2.3M | $2.2M | $2.1M | $2.0M | $1.7M | $1.7M | $1.6M | $1.5M | $1.5M | ||||||
| Other Assets Noncurrent | $4.5M | $4.9M | $4.9M | $4.9M | $4.9M | $4.9M | $4.9M | $4.8M | $4.8M | $4.8M | $4.9M | $5.6M | $2.0M | $2.0M | $847.0K | $846.0K | $846.0K | $419.0K | $419.0K | $419.0K | |||||||
| Accretion Amortization Of Discounts And Premiums Investments | $955.0K | $1.4M | $1.0M | $49.0K | -$4.0K | -$2.0K | |||||||||||||||||||||
| Restricted Cash Noncurrent | $336.0K | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | |||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $208.0K | $13.0K | $164.0K | $896.0K | -$192.0K | -$39.0K | -$172.0K | -$97.0K | $16.0K | -$163.0K | -$2.0K | -$24.0K | -$13.0K | -$7.0K | |||||||||||||
| Change In Fair Value Of Contingent Value Right Liability | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$1.7M | -$343.0K | $509.0K | |||||||||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $498.0K | $467.0K | $194.0K | $491.0K | |||||||||||||||||||||||
| Convertible Preferred Stock Converted To Other Securities | $0.00 | $3.5M | $7.0M | $16.2M | |||||||||||||||||||||||
| Offering Costs Included In Accounts Payable And Accrued Expenses | $0.00 | $282.0K | $0.00 | ||||||||||||||||||||||||
| Available For Sale Securities Debt Securities Current | $265.6M | $110.3M | $119.7M | $238.5M | $275.0M | $219.9M | $192.2M | $115.1M | $59.6M | $148.5M | |||||||||||||||||
| Property And Equipment Included In Accounts Payable And Accrued Expenses | $79.0K | $0.00 | $674.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $878.2M | $214.5M | $163.5M | $163.6M | $38.0M | $232.2M | $108.0K | $70.3M | -$729.0K |
| Investing Cash Flow * | -$399.5M | $38.3M | -$97.8M | -$124.7M | -$1.7M | $8.4M | $23.2M | -$10.5M | $13.6M |
| Operating Cash Flow * | -$264.4M | -$207.8M | -$153.6M | -$118.6M | -$58.8M | -$35.9M | -$41.5M | -$32.5M | -$25.8M |
| Share Based Compensation | $46.1M | $39.7M | $30.6M | $18.4M | $11.7M | $6.0M | $3.2M | $3.1M | $1.3M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $195.0K | $4.3M | $626.0K | $1.5M | $227.0K | $1.5M | $8.0K | $250.0K | $237.0K |
| Increase Decrease In Accounts Payable | -$2.5M | $1.4M | $4.8M | $2.4M | $2.8M | -$2.5M | $1.7M | $367.0K | -$31.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $10.7M | $16.0M | $8.2M | $9.6M | $3.4M | -$2.4M | $1.8M | $2.9M | $1.2M |
| Increase Decrease In Other Operating Assets | -$1.6M | -$2.0K | $119.0K | $1.0M | $3.7M | -$427.0K | $427.0K | $419.0K | |
| Payments To Acquire Property Plant And Equipment | $1.6M | $573.0K | $2.8M | $6.9M | $1.7M | $33.0K | $549.0K | $912.0K | |
| Increase Decrease In Operating Leases | -$1.6M | -$1.4M | -$796.0K | -$8.7M | -$2.1M | -$825.0K | -$1.5M | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $289.2M | $294.5M | $253.8M | $60.0M | $0.00 | $23.0M | $37.7M | $21.0M | |
| Proceeds From Stock Options Exercised | $11.5M | $199.0K | $965.0K | $1.2M | $24.0K | $512.0K | $108.0K | ||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 1.4M | 916.0K | 752.0K | 351.0K | 31.0K | 48.0K | |||
| Payments To Acquire Marketable Securities | $687.2M | $255.6M | $348.8M | $177.9M | $0.00 | $47.7M | $6.5M | ||
| Proceeds From Issuance Of Common Stock | $0.00 | $161.8M | $0.00 | $0.00 | $25.0M | $108.0K | $609.0K | $60.0K | |
| Increase Decrease In Accounts Receivable | -$2.0M | $332.0K | $838.0K | -$98.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $25.0M | $214.1M | $445.0K | $138.0K | -$85.0K | $73.0K | $11.0K | -$535.0K | |||||
| Investing Cash Flow * | $69.4M | $1.0M | $59.9M | -$441.0K | $15.0M | $5.9M | -$820.0K | ||||||
| Operating Cash Flow * | -$66.5M | -$52.5M | -$39.5M | -$28.3M | -$11.4M | -$7.9M | -$11.5M | -$8.0M | -$7.3M | ||||
| Share Based Compensation | $10.0M | $9.4M | $5.9M | $4.2M | $1.8M | $769.0K | $788.0K | $885.0K | $726.0K | $860.0K | $847.0K | $479.0K | $300.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$2.2M | $1.1M | $316.0K | $737.0K | -$1.4M | $414.0K | $17.0K | $668.0K | $185.0K | ||||
| Increase Decrease In Accounts Payable | $2.1M | $4.9M | -$1.7M | $532.0K | -$417.0K | -$2.6M | $317.0K | $1.3M | -$61.0K | ||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$8.7M | -$6.7M | -$2.6M | $199.0K | -$2.0M | -$1.0M | $696.0K | -$908.0K | |||||
| Increase Decrease In Other Operating Assets | $2.0K | $30.0K | $1.9M | -$427.0K | $427.0K | $419.0K | |||||||
| Payments To Acquire Property Plant And Equipment | $547.0K | $70.0K | $1.1M | $441.0K | $42.0K | $75.0K | $320.0K | ||||||
| Increase Decrease In Operating Leases | -$376.0K | -$330.0K | -$187.0K | -$550.0K | -$485.0K | -$387.0K | -$352.0K | ||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $69.9M | $74.1M | $120.0M | $15.0M | $6.0M | $4.0M | |||||||
| Proceeds From Stock Options Exercised | $136.0K | $0.00 | $132.0K | $9.0K | $38.0K | ||||||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 584.0K | 356.0K | 313.0K | 129.0K | 35.0K | ||||||||
| Payments To Acquire Marketable Securities | $73.0M | $59.0M | $4.5M | ||||||||||
| Proceeds From Issuance Of Common Stock | $38.0K | $11.0K | $28.0K | ||||||||||
| Increase Decrease In Accounts Receivable | -$2.0M | $372.0K | $771.0K | -$41.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$2.16 | -$1.94 | -$1.94 | -$1.73 | -$1.87 | -$16.17 | -$4.18 | -$1.39 | -$2.51 |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 60.0M |
| Common Stock Shares Issued | 161.0M | 110.5M | 86.1M | 69.9M | 43.8M | 32.3M | 7.7M | 30.1M | 10.2M |
| Common Stock Shares Outstanding | 161.0M | 110.5M | 86.1M | 69.9M | 43.8M | 32.3M | 7.7M | 30.1M | 10.2M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 38.7M | 11.1M | 7.6M | 24.9M | 10.2M | ||||
| Weighted Average Number Of Shares Outstanding Basic | 128.9M | 103.9M | 79.7M | 58.7M | 38.7M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 128.9M | 103.9M | 79.7M | 58.7M | 38.7M | ||||
| Earnings Per Share Basic | $-2.16 | $-1.94 | $-1.94 | $-1.73 | $-1.87 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 9.0M | 9.0M | 10.0M | 0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.50 | -$0.53 | -$0.52 | -$0.52 | -$0.43 | -$0.49 | -$0.64 | -$0.59 | -$0.55 | -$0.50 | -$0.71 | -$0.68 | -$0.48 | -$0.43 | -$0.34 | -$5.07 | -$0.95 | -$0.81 | -$1.56 | -$0.34 | -$0.39 | -$0.29 | -$0.34 | -$0.31 | -$0.66 | -$0.66 | -$0.69 | -$0.58 | -$0.58 | |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | ||||||||
| Common Stock Shares Issued | 139.8M | 113.9M | 113.9M | 110.5M | 109.3M | 95.6M | 86.1M | 85.3M | 70.9M | 69.9M | 65.7M | 45.8M | 39.9M | 39.8M | 37.2M | 31.2M | 30.8M | 30.7M | 30.7M | 30.1M | 29.9M | 29.9M | 10.2M | |||||||
| Common Stock Shares Outstanding | 139.8M | 113.9M | 113.9M | 110.5M | 109.3M | 95.6M | 86.1M | 85.3M | 70.9M | 69.9M | 65.7M | 45.8M | 39.9M | 39.8M | 37.2M | 10.7M | 31.2M | 30.8M | 30.7M | 30.7M | 30.1M | 29.9M | 29.9M | 10.2M | ||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 45.1M | 39.8M | 38.4M | 34.9M | 9.9M | 7.8M | 7.5M | 7.7M | 30.5M | 30.1M | 29.9M | 29.2M | 10.2M | 10.2M | 10.2M | 10.2M | ||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 137.6M | 114.5M | 113.3M | 110.2M | 99.2M | 94.8M | 86.2M | 74.8M | 70.7M | 69.6M | 49.4M | 45.1M | 39.8M | 38.4M | ||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 137.6M | 114.5M | 113.3M | 110.2M | 99.2M | 94.8M | 86.2M | 74.8M | 70.7M | 69.6M | 49.4M | 45.1M | 39.8M | 38.4M | ||||||||||||||||
| Earnings Per Share Basic | $-0.50 | $-0.53 | $-0.52 | $-0.52 | $-0.43 | $-0.49 | $-0.64 | $-0.59 | $-0.55 | $-0.50 | $-0.71 | $-0.68 | $-0.48 | $-0.43 | ||||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 9.0M | 9.0M | 9.0M | 9.0M | 9.0M | 9.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $14.7M | $18.1M | $13.1M | $4.0M | $467.0K | $144.0K | $267.0K | $1.2M | $386.0K |
| Costs And Expenses | $333.4M | $275.9M | $208.1M | $147.8M | $75.6M | $90.1M | $54.7M | $45.7M | $34.5M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $46.1M | $39.7M | $30.6M | $18.4M | $11.4M | $5.8M | $3.2M | ||
| Stock Issued During Period Value Stock Options Exercised | $11.5M | $199.0K | $965.0K | $1.2M | $24.0K | $512.0K | $108.0K | $609.0K | $60.0K |
| Depreciation And Amortization | $2.3M | $842.0K | $147.0K | $720.0K | $1.3M | $1.3M | $1.2M | ||
| Stock Issued During Period Value Employee Stock Purchase Plan | $1.4M | $916.0K | $752.0K | $351.0K | $31.0K | $48.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $3.9M | $2.4M | $3.0M | $4.8M | $5.4M | $4.1M | $4.2M | $2.7M | $2.3M | $1.5M | $272.0K | $107.0K | $115.0K | $120.0K | $125.0K | $23.0K | $3.0K | $47.0K | $31.0K | $25.0K | $150.0K | $405.0K | $259.0K | $81.0K | $100.0K | $97.0K | $90.0K |
| Costs And Expenses | $83.4M | $75.6M | $74.9M | $75.4M | $64.4M | $62.4M | $59.6M | $47.1M | $43.2M | $36.8M | $35.9M | $31.4M | $19.8M | $17.3M | $12.8M | $57.5M | $7.9M | $13.2M | $13.1M | $13.7M | $14.9M | $12.6M | $11.1M | $9.2M | $9.5M | $8.1M | $7.9M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $10.6M | $9.7M | $10.0M | $10.4M | $10.0M | $9.4M | $8.8M | $7.2M | $5.9M | $4.6M | $4.5M | $4.2M | $3.5M | $2.6M | $1.5M | $3.5M | $870.0K | $507.0K | $788.0K | $885.0K | $726.0K | ||||||
| Stock Issued During Period Value Stock Options Exercised | $1.0M | $5.0K | $136.0K | $63.0K | $109.0K | $356.0K | $731.0K | $102.0K | $132.0K | $914.0K | $9.0K | $24.0K | $335.0K | $62.0K | $38.0K | $97.0K | $11.0K | $175.0K | $11.0K | $28.0K | |||||||
| Depreciation And Amortization | $640.0K | $599.0K | $529.0K | $69.0K | $17.0K | $295.0K | $330.0K | $314.0K | $278.0K | ||||||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $766.0K | $584.0K | $561.0K | $356.0K | $439.0K | $313.0K | $222.0K | $129.0K | $31.0K | $13.0K | $35.0K |
Most recent annual filing with the SEC: February 17, 2026
Data sourced from SEC EDGAR public filings as of August 9, 2026.